Vincristine negatively affects musculoskeletal growth in young mice - Top-Institutions - MDSpire

Vincristine negatively affects musculoskeletal growth in young mice

  • By

  • Nicholas A. Jamnick

  • Patrick D. Livingston

  • Caleb J. Gammon

  • Natalia M. Weinzierl

  • Leah J. Novinger

  • Douglas J. Adams

  • Andrea Bonetto

  • November 18, 2025

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Oncology
    • Musculoskeletal Biology
    • Translational Research

  • #2

    Dana-Farber Cancer Institute / Boston Children's Hospital
    Dana-Farber Cancer Institute / Boston Children's Hospital

    Boston, MA

    Key Differentiators

    • Pediatric Oncology
    • Muscle and Bone Biology
    • Cancer Survivorship

  • #3

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Oncology
    • Musculoskeletal Development
    • Translational Medicine

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Pediatric Oncology
    • Muscle Biology
    • Cancer Therapeutics

Original Source(s)

Vincristine negatively affects musculoskeletal growth in young mice

  • by Nicholas A. Jamnick, Patrick D. Livingston, Caleb J. Gammon, Natalia M. Weinzierl, Leah J. Novinger, Douglas J. Adams, Andrea Bonetto

  • November 18, 2025

Related Content

Understanding the Role of Regulatory T Cells in the Immune Microenvironment of Multiple Myeloma and Its Clinical Implications

Exploring Pediatric Secondary Hemophagocytic Lymphohistiocytosis: An In-Depth Review of Causes, Diagnostic Methods, and Treatment Options

This Week’s CGT News: New FDA Genome Editing Guidance 

Our latest roundup highlights tighter FDA expectations for genome editing safety, advances in CRISPR precision and delivery, and continued momentum for off-the-shelf CAR-T

  • April 20, 2026

  • 6 min